miR-19 promotes osteosarcoma progression by targeting SOCS6 Zhengwen Sun et al, 2018, Biochemical and Biophysical Research Communications CrossRef
Bone Cancer: Dysregulation of Signaling Cascades by microRNAs Janaina de Andréa Dernowsek, 2018, Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs CrossRef
A Novel Predictive Model Associated with Osteosarcoma Metastasis Han Zhang et al, 2021, Cancer Management and Research CrossRef
miR-486-5p expression is regulated by DNA methylation in osteosarcoma Heidi M. Namløs et al, 2022, BMC Genomics CrossRef
The clinical utility of dysregulated microRNA expression in paediatric solid tumours Karan R. Chadda et al, 2022, European Journal of Cancer CrossRef
Comparison of Oncogenes, Tumor Suppressors, and MicroRNAs Between Schizophrenia and Glioma: The Balance of Power James S. Brown, 2023, Neuroscience & Biobehavioral Reviews CrossRef
Multifunctional nanomaterials via cell cuproptosis and oxidative stress for treating osteosarcoma and OS-induced bone destruction Lin Ye et al, 2024, Materials Today Bio CrossRef
Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing Dong‑Yue Wen et al, 2018, Molecular Medicine Reports CrossRef
miRNA signatures in childhood sarcomas and their clinical implications G. M. Viera et al, 2019, Clinical and Translational Oncology CrossRef
Elevated Expression of miR-629 Predicts a Poor Prognosis and Promotes Cell Proliferation, Migration, and Invasion of Osteosarcoma
Xuesen Li et al, 2020, OncoTargets and Therapy CrossRef
miR‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma Chengwen Sun et al, 2019, Molecular Medicine Reports CrossRef
miR-486 is involved in the pathogenesis of acute myeloid leukemia by regulating JAK-STAT signaling Cao Sha et al, 2021, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
Analysis of miRNA-mRNA Crosstalk in Radiation-Induced Mouse Thymic Lymphomas to Identify miR-486 as a Critical Regulator by Targeting IGF2BP3 mRNA Hainan Zhao et al, 2021, Frontiers in Oncology CrossRef
Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications Jinxin Tang et al, 2023, Biomarker Research CrossRef
Development and validation of neutrophil extracellular traps-derived signature to predict the prognosis for osteosarcoma patients Yunhua Lin et al, 2024, International Immunopharmacology CrossRef
MiRNAs as Novel Adipokines: Obesity-Related Circulating MiRNAs Influence Chemosensitivity in Cancer Patients Sarah B. Withers et al, 2020, Non-Coding RNA CrossRef
miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1 Haibin Yan et al, 2018, Anti-Cancer Drugs CrossRef
Long noncoding RNA SLC9A3‑AS1 increases E2F6 expression by sponging microRNA‑486‑5p and thus facilitates the oncogenesis of nasopharyngeal carcinoma Jiansheng Li et al, 2021, Oncology Reports CrossRef
miR-486 inhibited osteosarcoma cells invasion and epithelial-mesenchymal transition by targeting PIM1 Yuhan Liu et al, 2018, Cancer Biomarkers CrossRef
Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway Liujing Qu et al, 2024, Frontiers in Oncology CrossRef
Long non-coding RNA ZFAS1 sponges miR-486 to promote osteosarcoma cells progression and metastasis in vitro and vivo Nan Li et al, 2017, Oncotarget CrossRef
The Correlation Analysis of miRNAs and Target Genes in Metastasis of Cervical Squamous Cell Carcinoma Jing Zhou et al, 2018, Epigenomics CrossRef
MicroRNA copy number alterations in the malignant transformation of pleomorphic adenoma to carcinoma ex pleomorphic adenoma Talita de Carvalho Kimura et al, 2024, Head & Neck CrossRef
Exosome‑delivered miR‑486‑3p inhibits the progression of osteosarcoma via sponging CircKEAP1/MARCH1 axis components Huidong Yang et al, 2023, Oncology Letters CrossRef